| |
BOOKS AND BOOK CONTRIBUTIONS
Bullock, R.A., (2002) Building A Modern Dementia Service.
2002 Altman Publishing
(To
order from
Amazon.co.uk, click here)
Bullock, R.A., Qizilbash,
N., (2002) Memory Clinics - A Guide to Implementation and Evaluation.
Section VII.7 pp 828-843 in Evidence-based Dementia Practice. Edited
Qizilbash, N., Schneider, L., Chui, H., Tariot, P., Brodaty, H., Kaye,
J., Erkinjuntti, T. 2002 Blackwell Science Ltd., Oxford
 Naidoo,
M., Bullock, R.A., (2001) Breaking Down the Walls of Silence.
The Development of an integrated care pathway for dementia. Harcourt,
London February 2001
(Click
here for full details)
Naidoo, M., (1999)
Facilitating multi-professional clinical audit or "how to keep
your balloon up without the hot air" p 130-131 in The Clinical
Audit Handbook. Improving the quality of health care. Morrell, C., Harvey,
G. 1999 Bailliere Tindall, London.
PAPERS AND ARTICLES PUBLISHED
[2003]
Bullock, R. A., (2003)
Vascular dementia - a suitable case for treatment. The British
Journal of Cardiology (Heart & Brain), Vol 10, Issue 1, pp 20 -
23, March 2003
Connolly, C. M., Bullock,
R. A., (2003) Treatment of patients with Alzheimer's disease:
a national survey following release of the NICE guidelines. Psychiatric
Bulletin, Vol 27, No 1 pp 11 - 13, January 2003
[2002]
Bullock R. A., Sorensen
S., Shih T., Meletiche D., Sadik K. (2002) Analysis of the risk
of falls and cost consequences in patients receiving galantamine or
placebo. Journal of Clinical Psychiatry, Vol 63, No 11, p1059, November
2002
Aarsland D., Alhainen
K., Bullock R. A., Wetterberg P., Smith R., Soininen H., Murthy A.,
Zhang R., Bahra R., (2002) First head to head study comparing
the tolerability and satisfaction/ease of use of donepezil and galantamine
in Alzheimer's disease. European Neuropsychopharmacology, Vol 12,
Supplement 3, p384, October 2002
Soininen H., Martin S.,
Bullock R. A., Alhainen K., Hager K., Jones R., Aarsland D., Murthy
A., Zhang R., Bahra R., (2002) First head to head study comparing
the efficacy of donepezil and galantamine in Alzheimer's disease.
European Neuropsychopharmacology, Vol 12, Supplement 3, pp 385 - 386,
October 2002
Bullock, R. A., (2002)
Can Damocles rediscover Hippocrates - what is the developing role of
the clinical director? Clinician in Management, Vol 11, No 2, pp
61 - 66, Autumn 2002
Bullock R. A., Gambina
G., Lane R., Nagel J., (2002) Rationale and design of EXCEED,
a 24-month, double-blind study comparing rivastigmine and donepezil.
Annals of Neurology, Vol 52, No 3, Supplement 1, p30, September
2002
Bullock, R. A., (2002)
Shared care pathways. Geriatric Medicine - care of the elderly
in Alzheimer's disease supplement, Vol 32, No 9, pp 6-7, September 2002
Bullock, R. A., Saharan,
A., (2002) Atypical Antipsychotics: Experience and Use in the
Elderly, International Journal of Clinical Practice, Vol 56, No
7, pp515-525, September 2002
Wilkinson D. G., Passmore
A. P., Bullock R. A., Hopker S. W., Smith R., Potocnik F. C. V., Maud
C. M., Engelbrecht I., Hock C., Ieni J. R., Bahra R. S., (2002)
A multinational, randomised, 12-week, comparative study of donepezil
and rivastigmine in patients with mild to moderate Alzheimer's disease.
International Journal of Clinical Practice, Vol 56, No 6, pp 441-446,
July - Aug 2002
Kessler J, Kalbe E, Smith
R, Bullock R. A., Fischer L, Calabrese P., (2002) Correlation
analysis of Demtect (R) subtests with the mini-mental state examination
in patients with dementia, mild cognitive impairment, and aged controls.
Neurobiology of Aging, Vol 23, No 1, Supp 1, p 127, July - Aug 2002
Passmore P., Wetterberg
P., Adler G, Bullock R. A., Soininen H., Aarsland D., Murthy A., Zhang
R., Bahra R., (2002) First head to head study comparing the tolerability,
ease of use, and efficacy of donepezil and galantamine in Alzheimer's
disease. Neurobiology of Aging, Vol 23, No 1, Supp 1, p 367, July
- Aug 2002
Bullock R. A., Wesnes
K. (2002) Cholinesterase inhibitors and executive function.
Neurobiology of Aging, Vol 23, No 1, Supp 1, p 492, July - Aug 2002
Marriott A, Bullock R.
A. (2002) Functional change before dementia. Neurobiology
of Aging, Vol 23, No 1, Supp 1, p 524, July - Aug 2002
Marriott A. S., Bullock
R. A. (2002) The evolving role of a memory clinic. Neurobiology
of Aging, Vol 23, No 1, Supp 1, p 586, July - Aug 2002
Bullock R. A., Saharan
A. (2002) Cigarette smoking as a differential diagnosis of cognitive
impairment. Neurobiology of Aging, Vol 23, No 1, Supp 1, p 642,
July - Aug 2002
Bullock R. A., Wesnes
K. (2002) Attention in the differential diagnosis of dementia.
Neurobiology of Aging, Vol 23, No 1, Supp 1, p 990, July - Aug 2002
Bullock, R. A., Cameron,
A., (2002) Rivastigmine for the Treatment of Dementia and Visual
Hallucinations Associated with Parkinson's Disease: A Case Series.
Current Medical Research And Opinions, Vol 18, No 5, pp 258-264, July
2002
Bullock, R. A., (2002)
Why subspecialise? Old Age Psychiatrist, pp4-5, Summer 2002
Bullock, R. A., (2002)
Clinical governance, the emperor's new clothes and the meaning of
clinical audit. Journal of Clinical Excellence Vol 4, 2002
Bullock, R. A., (2002),
Increased risk of Alzheimer's disease in mothers who gave birth to children
with Down's syndrome before 35 years of age (Comment on paper in Neurology.
2001 Sep 25;57(6):979-84) Evidence Based Mental Health Vol 5, No
2, p61 May 2002
Kalbe E., Kessler J.,
Smith R., Bullock R. A., Fischer L., Calabrese P. (2002) The DemTect
(R): a very sensitive screening instrument for mild dementia. European
Psychiatry Vol17, Supp 1, p131S, May 2002
Bullock, R. A., (2002)
Shared-care protocols. Dementia Bulletin, Sponsored Educational
Supplement, May 2002
Bullock, R. A., (2002)
The Clinical Benefits of Rivastigmine May Reflect Its Dual Inhibitory
Mode of Action: An Hypothesis. International Journal of Clinical
Practice, Vol 56, No 3, pp206-214 April 2002
Bullock, R. A., Libretto,
S., (2002) Risperidone in the treatment of psychoses in the elderly:
a case report series. European Psychiatry, Vol 17, No 2, pp 96-103
April 2002
Erkinjuntti, T., Kurz,
A., Gauthier, S., Bullock, R. A., Lilienfeld, S., Rao, C., Damaraju,
V., (2002) Efficacy of galantamine in probable vascular dementia
and Alzheimer's disease combined with cerebrovascular disease: a randomised
trial. The Lancet, Vol 359, pp1283-90, April 2002
Bullock, R. A., Connolly,
C., (2002) Switching cholinesterase inhibitor therapy in Alzheimer's
disease - donepezil to rivastigmine, is it worth it? (research letter).
International Journal of Geriatric Psychiatry Volume 17, pp 288-289
April 2002
Bullock, R. A., (2002)
New Drugs for Alzheimer's Disease and Other Dementias British
Journal of Psychiatry, vol. 180, PP 135-139 February 2002
Voss, S. E., (2002)
The winter years - Understanding ageing Psychology Review, Volume
8, Number 3 PP 26-27 February 2002
Bullock, R. A., (2002)
Linking science to efficacy Rapid Report Issue 1, 2002
[2001]
Bullock, R. A., (2001) Effects of rivastigmine on behavioural
symptoms in nursing home patients with Alzheimer's disease. European
Neuropsychopharmacology (Supplement) November 2001
Bullock, R. A., Wesnes, K. A. (2001) The emerging importance
of attention and the speed of cognitive function in ageing and dementia
research. CPD Bulletin Old Age Psychiatry Vol. 3, No 1, pp11-15
Bullock, R. A., (2001)
Improving the use of antipsychotics in the elderly - atypicals, a first
line option? Geriatric Medicine Summer 2001
Bullock, R.A., (2001)
No more ifs, ands or buts. Old Age Psychiatrist Summer 2001,
pp7-8
Bullock, R. A., (2001)
Commentary - Drug switching in AD: focus on cholinesterase inhibitors
Alzheimer's Insights Vol. 7, No 2, June 2001
Bullock, R. A., Lillenfeld,
S., (2001) Galantamine shows promising results in Alzheimer's
Disease with cerebrovascular components and probable vascular dementia
(preliminary results) - Poster Abstract. Journal of the Neurological
Sciences Vol. 187, Supp 1, 15th June 2001, p59
Bullock, R. A., (2001)
The problem of centralisation. Journal of Clinical Excellence
, Vol 3., No. 3, 2001
Voss, S. E., Bullock,
R. A.. Rose, C., (2001) Don't Forget. Geriatric Medicine
May 2001, pp51-53
Bullock, R. A., (2001)
Pathways from science to effective patient management in dementia
Rapid Report Issue 2, May 2001
Bullock, R. A., (2001)
Rivastigmine and behaviour - A European nursing home study Rapid
Report Issue 2, May 2001
Bullock, R. A., (2001)
Switching strategies with cholinesterase inhibitors Rapid Report
Issue 2, May 2001
Bullock R. A., Passmore
P., Potocnik F., Hock C. (2001) The tolerability, ease of use and
efficacy of donepezil and rivastigmine in Alzheimer's disease patients:
A 12-week, multinational, comparative study. Journal of the American
Geriatrics Society, Vol 49, No 4, p12, April 2001
Naidoo, M. J., Bullock,
R. A., (2001) Breaking down the walls of silence: the development
of an integrated care pathway for dementia. Journal of Clinical
Excellence , Vol. 3., No. 1, 2001, pp11-13
Brooke, P., (2001)
The view from primary care. Old Age Psychiatrist Spring 2001,
p11
Bullock, R. A., (2001)
Go to primary care. Old Age Psychiatrist Spring 2001, p8
Bullock, R. A., (2001)
Contributing Author to "The Case for Long-term Drug Treatment".
Alzheimer's in FOCUS. March 2001
Bullock, R. A., (2001)
Editorial . . . Nice guidance on drugs for Alzheimer's disease.
Update. 8 March 2001, p 19
Bullock, R. A., (2001)
Drug treatment in dementia. Current Opinion in Psychiatry 2001
- 14. , PP 349-353
Bullock, R. A., (2001)
The poorly performing old age psychiatrist. CPD Old Age psychiatry
2001 - Vol. 2, No 2.
Bullock, R. A., (2001)
Good News from NICE. Geriatric Medicine February 2001, Volume 31,
No 2, P266
[2000]
Bullock, R. A., (2000)
Fun and Science at 7th World Alzheimer's Congress, Washington,
D.C., July 2000. IPA Bulletin December 2000, pp11-12
Bullock, R. A., (2000)
Armchair theatre. Health Service Journal 1 June 2000, pp22-23
Brooke, P., (2000)
A better test for cognitive loss. The Practitioner Volume 244
May 2000 p389 & 463
Bullock, R. A., (2000)
Old Age Psychiatry: beyond the adolescent crisis. Old Age Psychiatrist
Millennium Issue pp12-13.
Bullock, R. A., (2000)
To Help the Aged get them out of hospital. Sunday Times 9/4/2000
Brooke, P., (2000)
Screening for dementia in the elderly population. Progress in
Neurology and Psychiatry Volume 4 Issue 2 March/April 2000 pp17-19
Campbell, S., Rose, C.
A., (2000) A Problem Shared… Health Management March
2000 pp22-23.
Coyle, F., Bullock R.
A., Junaid, O., (2000) Challenge. Diagnosing and managing disturbed
behaviour. Geriatric Medicine March 2000 pp56-58
Jones-Ritson, M., Bullock,
R. A., (2000) Does Oestrogen Protect the Male Brain Too? A case
of Oestrogen Withdrawal in a Man Reveals Underlying Dementia. International
Journal of Geriatric Psychiatry 15, PP 282-285 Letter.
Jones-Ritson M., Bullock
R. A., (2000) Current Awareness. International Journal of Geriatric
Psychiatry; Vol 15, No 3, pp 287-294, March 2000
Bullock, R. A., (2000)
Review: rivastigmine may improve cognitive outcomes in Alzheimer's
disease. Commentary. Evidence-based Mental Health Vol. 3 February
2000 p10.
Bullock, R. A., Passmore,
P., Wilkinson, D., Howard, R., Jones, R.,(2000) Effectiveness
of Rivastigmine in Alzheimer's diseas British Medical Journal Vol.
320 19th February 2000 Letter.
[1999]
Brooke, P, Jones-Ritson,
M, Bullock, R. A., (1999) Treatment-Refractory Depression in
the Elderly: An Audit of Primary Care Referrals to Psychiatric Services
in Swindon, UK. The Primary Care Companion To the Journal of Clinical
Psychiatry Volume 1 Number 6 December 1999.
Brooke, P., Bullock R.
A., (1999) Validation of a 6 item Cognitive Impairment Test with
a View to Primary Care Usage. International Journal of Geriatric
Psychiatry 14, pp936-940.
Dukes, C., (1999)
Drug Therapy in Alzheimer's disease. Update 19th August 1999.
Voss, S. E., Bullock,
R. A., Elcock, J., (1999) A memory clinic in a department of
old-age psychiatry: It's role in clinical and academic research.
International Journal of Psychiatry in Clinical Practice
Dukes, C., (1999)
Drug Therapy in Alzheimer's disease. Update 19th August 1999.
Voss, S. E., (1999)
A Future in the Past. Community Care: The magazine for everyone
in social care. 10th -16th June 1999
Brooke, P., (1999)
Care Pathways in Old Age Psychiatry: can we improve? Progress in
Neurology and Psychiatry PP 34 - 37
Bullock, R. A., (1999)
Review commentary: hydergine leads to greater global improvement and
greater improvement on comprehensive rating scales in dementia. Commentary.
Evidence-based Mental Health February 1999 Vol. 2 No 1.
Bullock, R. A., (1999)
Review Commentary: hydergine leads to greater global improvement and
greater improvement on comprehensive rating scales in dementia. Commentary.
Evidence-based Mental Health February 1999 Vol 2 No 1 p 15.
[1998]
Palmer C., Bullock R.
A., Orrell M.,(1998) Evidence Base Briefing: Dementia.
Bullock, R. A., (1998)
Drug treatment for early Alzheimer's Disease. Advances in Psychiatric
Treatment 4, pp 126-134
Bullock, R. A., Baldwin,
D., Hawley, C., Szabadi, E., Burgess, J., Thomson, J., Lagnado, M.,
(1998) Reboxetine in the treatment of depression: Early clinical experience
in the UK. International Journal of Psychiatry in Clinical Practice
September 1998 Vol 2 No 3 pp195 - 201
Bullock, R. A., (1998)
Reboxetine in the treatment of depression: Early clinical experience
in the UK. International Journal of Psychiatry in Clinical Practice
September 1998 Vol. 2 No 3 pp195 - 201
Bullock, R. A., (1998)
Can we realistically manage the poorly performing old age psychiatrist?.
British Medical Journal. 21st March, Vol. 316 PP 875-876
[1994]
Bullock, R. A., (1994)
Use of approval visits by the CTC. Psychiatric Bulletin April
1994 Vol. 18 No 4
[1993]
Castle, D., Bullock, R.
A., (1993) 1993 Trainees' Forum 'The Mental Health of the Nation'.
Psychiatric Bulletin (1993) 17, 376.
Tannock, C., Bullock,
R. A., Peatfield R. C., (1993) Problem Drinkers do not get headache.
Cephalalgia 1993;13;365.
PAPERS PRESENTED
[2003]
Wesnes, K., Bullock, R.
A., Lilienfeld, S., Mahableshwarkar, A., and Members of the GAL-GBR-2
Study Group (2003) Galantamine and donepezil in the treatment of
Alzheimer's disease: effects and cognition. 2003 American Psychiatric
Association Annual Meeting, San Francisco, USA, 17th - 22nd May 2003
Sadick, K., Bullock R.
A., (2003) Galantamine lowers the risk and decreases the cost
of fall-related injuries compared with placebo. American Geriatric
Society Annual Conference 2003, Baltimore, USA, 14th - 18th May 2003
Bullock, R. A., Pratt,
R. D., Perdomo, C. A., and the donepezil 307 and 308 VaD study groups
(2003) Donepezil is well tolerated in patients with vascular dementia:
a comparison of tolerability in vascular dementia patients and Alzheimer's
disease patients. 6th International Conference Alzheimer's Disease
and Parkinson's Disease (AD/PD), Seville, Spain, 8th - 12th May 2003
Bullock, R. A., (2003)
Confirmation and Differentiation Strategies of Dementia Sub-types.
AAGP Satellite Symposium Waikiki, Hawaii, 1st - 4th March 2003
[2002]
Voss, S. E., Bullock,
R. A. (2002) Executive Control Functions (ECF) Vs Memory: The
battle for supremacy in dementia. UK Dementia Research Group Annual
Conference, Wolverhamtpon, UK, 30th October 2002
Kessler, J., Kalbe, E.,
Smith, R., Bullock, R. A., Fischer, L., Calabrese, P., (2002) Detecting
MCI patients with DemTect®. 6th Congress of the European Federation
of Neurological Societies (EFNS), Vienna, Austria, 26th - 29th October
2002
Bullock, R. A., (2002)
The effect of Galantamine on patients with advanced Alzheimer's disease.
18th International Conference of Alzheimer's Disease International,
Barcelona, Spain, 23rd - 26th October 2002
Kessler, J., Kalbe, E.,
Smith, R., Bullock, R. A., Fischer, L., Calabrese, P., (2002) Correlation
analysis of DemTect® subtests with the Mini-Mental State Examination
in patients with dementia, mild cognitive impairment, and aged controls.
8th International Conference on Alzheimer's Disease and Related Disorders
Stockholm, Sweden, 21st - 25th July 2002
Bullock, R .A., Wesnes,
K., (2002) Cholinesterase inhibitors and executive function
8th International Conference on Alzheimer's Disease and Related Disorders,
Stockholm, Sweden, 21st - 25th July 2002
Naidoo, M. J., Bullock,
R. A., (2002) Merging Cultures New Approaches to the Management
of Dementia - Achieving Integrated Care Pathways. London, 2nd July
2002
Bullock, R. A., Truyen,
L., (2002) Long-term response to Galantamine in patients with
Alzheimer's disease (AD), vascular dementia or AD with cerebrovascular
disease. 12th Meeting of the European Neurological Society, Berlin,
Germany, 22nd - 26th June 2002
Voss, S. E., (2002)
The role of Executive Control Function (ECF) in Dementia, Post
Graduate Conference, Department of Experimental Psychology, University
of Bristol, 17th June 2002
Kessler, J., Kalbe, E.,
Smith, R., Bullock, R. A., Fischer, L., Calabrese, P., (2002) A
comparison of DemTect® subtests with the Mini-Mental State Examination
in patients with dementia, individuals with mild cognitive impairment,
and aged controls. International Psychiatric Association European
and Mediterranean Regional Meeting, Rome, Italy, 17th - 20th April 2002
Bullock, R. A., (2002)
Ageing, Mental Health and Mental Illness. International Conference
on Mental Health & Psychiatry, Colombo, Sri Lanka, 4th -
7th April 2002
Kalbe, E., Kessler, J.,
Smith, R., Bullock, R. A., Fischer, P., Calabrese, P., (2002) DemTect®:
A New Screening Instrument With Very High Sensitivity for Vascular and
Alzheimer Dementia Second International Congress on Vascular Dementia,
Salzburg, Austria, 24th - 27th January 2002
Bullock, R. A., Wesnes,
K., (2002) The Effect of Cholinesterase Inhibitors on Executive
Function. Second International Congress on Vascular Dementia, Salzburg,
Austria, 24th - 27th January 2002
Bullock, R. A., (2002)
Use of Nimodipine in the elderly. 2nd Panhellenic Congress of
Alzheimer's Disease, Thessaloniki, Greece, 18th - 20th January 2002
[2001]
Naidoo, M. J., (2001)
Applying creative arts and complexity science to quality improvement.
13th Annual National Forum on Quality Improvement in Health Care, Orlando,
Florida, 9th - 12th December 2001
Naidoo, M. J., Bullock,
R. A., Brooke, P., (2001) Symposium on recognition and care of
dementia sufferers. Alzheimer's Disease International 17th International
Conference, Christchurch, New Zealand, 25th - 27th October 2001.
Bullock, R. A., (2001)
Key data and dosing: from the perspective of the prescriber. Alzheimer's
Disease International 17th International Conference (Satellite), Christchurch,
New Zealand, 25th - 27th October 2001.
Bullock, R. A., Wilkinson,
D. G., Passmore, P., Hopker, S. W., Smith, R., Potocnik, F. C. V. Maud,
C. M., Hock, C., (2001) Caregiver and physician determination
of the ease of use and satisfaction of treatment with donepezil and
rivastigmine in AD patients. Alzheimer's Disease International 17th
International Conference, Christchurch, New Zealand, 25th - 27th October
2001.
Naidoo,M. J. (2001)
"Breaking Down the Walls of Silence" Collaborative Dementia
Programme. 18th International Conference of the International Society
for Quality in Health Care, Buenos Aries, Argentina, 2nd - 5th October
2001
Naidoo, M., (2001)
Applying creative arts and complexity science to quality improvement.
1st Asia Pacific Forum on Quality Improvement in Health Care, Sydney,
Australia, 19th - 21st September 2001
Bullock, R. A., Voss,
S. E., (2001) Executive functioning in dementia: Neuropsychological
comparison of Vascular and Alzheimer's disease. Tenth Congress of
the International Psychogeriatric Association, Nice, France, 9th - 14th
September 2001.
Bullock, R. A., (2001)
'Meet the Experts' Session - Practical guidelines for the use of Galantamine.
17th World Congress of Neurology London, UK, 17th - 22nd June 2001
Bullock, R. A., (2001)
What are the current expectations of a memory clinic? 3rd National
Memory Clinic Conference, Reading, 5 June 2001
Bullock, R. A., (2001)
Commissioning memory clinics. 3rd National Memory Clinic Conference,
Reading, 5 June 2001
Bullock, R. A., (2001)
A Care pathway in dementia. Faculty in Old Age Psychiatry Annual
Meeting, Dublin, March 2001
Naidoo, M. J., (2001)
"Breaking Down The Walls of Silence", the development of an
integrated care pathway for dementia. 6th European Forum On Quality
Improvement in Health Care, Bologna, Italy 29th - 31st March 2001.
Naidoo, M. J., (2001)
"Breaking Down The Walls of Silence", the development of
an integrated care pathway for dementia. College of Speech and Language
Therapists, London, January 2001.
Bullock, R. A., (2001)
Scoping the issues in Old Age Psychiatry, Kings Fund/CMHSD Issues
in Elderly Mental Health Conference, London, January 2001
[2000]
Naidoo, M. J., (2000)
"Breaking Down The Walls of Silence", the development of an
integrated care pathway for dementia. 12th Annual National Forum
on Quality Improvement in health Care, San Francisco, USA 5th-8th December
2000.
Naidoo, M. J., (2000)
"Breaking Down The Walls of Silence", the development of
an integrated care pathway for dementia. Clinical Excellence 2000
- Setting Standards and Spreading Good Practice, Harrogate 28th - 30th
November 2000.
Naidoo, M. J., (2000)
"Breaking Down The Walls of Silence", the development of
an integrated care pathway for dementia. 1st International Quality
Research in Dementia Conference, Westminster, London 19th - 22nd November
2000.
Voss S., Bullock R. A.,
(2000) Assessment in dementia: neuropsychology and differential diagnosis.
1st International Quality Research in Dementia Conference, Westminster,
London 19th - 22nd November 2000.
Rose, C. A., Warren, A.,
Lewis, L., The Forget Me Not Centre (a service for younger people
with dementia). Doncaster & South Humber Healthcare NHS Trust
Conference, Doncaster 31 October 2000.
Bullock R. A., Voss S.,
The Longitudinal Basis of Mild Cognitive Impairment (MCI).
World Alzheimer's Congress 2000, Washington USA July 9-18 2000.
Bullock, R. A., Rose
C. A., Integration of Community Mental Health Services. Royal
College of Psychiatrists Annual Meeting. Edinburgh 3rd - 7th July 2000.
Bullock R. A., An
overview of evidence-based practice in old age mental health. Clinical
Effectiveness in Mental Health Services for Older People. The Commonwealth
Institute, London 23rd May 2000.
Bullock R. A., Voss S.,
(2000) Mild Cognitive Impairment - and what it means to future services.
Innovations in Psychiatry, London 6th April 2000.
Bullock, R. A., (2000)
A Care Pathway for Dementia including evidence and costings.
Innovations in Psychiatry, London 6th April 2000.
[1999]
Brooke, P., Bullock, R.
A., (1999) The 6 Item Cognitive Impairment Test: An international
screening tool for dementia? Alzheimer's Disease International,
15th International Conference, Johannesburg, S Africa, 16-18 September
1999.
Bullock, R. A., (1999)
The factsheet on the drug treatment of dementia. Alzheimer's
Disease International, 15th International Conference, Johannesburg,
S Africa, 16-18 September 1999.
Voss, S. E., Elcock,
J., Bullock, R. A., (1999) Development of a neuropsychological
test battery for differential diagnosis of dementia. IPA: Ninth
Congress "Challenges for the new Millennium", at Vancouver,
Canada, August 1999
Voss, S. E., Elcock,
J., Bullock, R. A., (1999) MCI and mild dementia: A continuum
or nosological identity? IPA: Ninth Congress "Challenges for
the new Millennium", at Vancouver, Canada, August 1999.
Voss, S. E., Elcock,
J., Bullock, R. A., (1999) Differential cognitive impairment
in dementia: Use of MMSE and a neuropsychological test battery.
BPS 1999 Annual Conference at Waterfront Hall, Belfast, 8-11 April 1999.
Bullock, R. A., (1999)
AAMI Fact or Fiction. American Association for Geriatric Psychiatry,
New Orleans USA, 14-17 March 1999.
[1998]
Bullock, R. A., Voss,
S. E., (1998) The use of Donepezil in clinical practice.
2nd South and West Public Health Conference; at Dillington House, Somerset,
May 1998
Voss, S. E., Burgess,
I.S., Elcock, J., Bullock, R. A., (1998) The Hopkins Verbal Learning
Test in the Detection of Dementia. The UK Dementia Research Group
Conference; at the University of Leicester, April 1998
[1996]
Voss, S. E., Percy, C.,
(1996) Attitudes towards Homosexuality: Views from the Beholder and
the Beheld. Paper presented to The Annual Conference of the Women's
Section of the British Psychological Society; the University of the
West of England, July 1996.
Bullock, R. A., (1996)
Choosing a Consultant Post in Old Age Psychiatry. The Psychiatry
of Old Age Annual Residential Conference; at Europa Hotel, Belfast,
March 1996
Bullock, R. A. (1994)
User empowerment - threat or opportunity? Royal College of Psychiatry
Annual Meeting, Cork, Ireland, July, 1994,
POSTERS PRESENTED
[2003]
Bullock R. A., Lillienfeld,
S., Mahableshwarkar, A. (2003) Galantamine (Reminyl) Demonstrates
Greater Treatment Response Than Donepezil (Aricept) in 52 Weeks of Active
Treatment of Patients With Alzheimer's Disease: A Responder Analysis.
American Geriatric Society Annual Conference 2003, Baltimore, USA,
14th - 18th May 2003
Bullock R. A., Lillienfeld,
S., Mahableshwarkar, A. (2003) Greater Reduction in Caregiver
Burden for Galantamine (Reminyl) Than Donepezil (Aricept) in 52 Weeks
of Active Treatment of Patients With Alzheimer's Disease. American
Geriatric Society Annual Conference 2003, Baltimore, USA, 14th - 18th
May 2003
Bullock, R. A., Wesnes,
K., Mahableshwarkar, A., Schwalen, S., and the GAL-GBR-2 Study Group,
(2003) Galantamine demonstrates greater efficacy than donepezil in
52 weeks of active treatment of patients with Alzheimer's disease: an
initial analysis. Third Kuopio Alzheimer Symposium, Kuopio, Finland,
21st - 22nd March 2003
Bullock, R. A., Erkinjuntti,
T., Kafferlein, W., Wetterberg, P., Murthy, A., Blackburn, S., Bahra,
R., (2003) Greater improvement in cognition and ativities of
daily living with donepezil compared to galantamine in a direct head-to-head
trial in Alzheimer patients. American Association of Geriatric Psychiatry
Annual Meeting, Waikiki, Hawaii, 1st - 4th March 2003
[2002]
Bullock, R. A., Mahableshwarker,
A., Lilienfeld, S., and the GAL-GBR-2 Study Group (2002) Galantamine
(Reminyl) demonstrates a greater treatment response than donepezil (Aricept)
in patients with Alzheimer's disease actively treated for 52 weeks.
41st Annual Meeting of the American College of Neuropsychopharmacology
(ACNP), San Juan, Puerto Rico, 8th - 12th December 2002
Bullock, R. A., Hager,
K., Smith, R., Murthy, A., Zhang, R., Bahra, R., (2002) Donepezil
compared with Galantamine in Alzheimer's Disease: Better Physician and
Caregiver Satisfaction/Ease of Use Ratings in a Multinational Randomized
Trial. American Society of Consultant Pharmacists' 33rd Annual Meeting,
Anaheim, USA, 13th - 16th November 2002
Kurz, A., Erkinjuntti,
T., Bullock, R. A., Lilienfeld, S., Brashear, H. R. (2002) Long-term
safety and efficacy of galantamine in the treatment of probable vascular
dementia or Alzheimer's disease with cerebrovascular disease: an interim
analysis. American Society of Consultant Pharmacists' 33rd Annual
Meeting, Anaheim, USA, 13th - 16th November 2002
Marriott, A., Bullock,
R. A., (2002) Can the Bayer Activities of Daily Living Scale
assist in the early diagnosis of dementia? UK Dementia Research
Group Annual Conference, Wolverhampton, 30th October 2002
Cima, L., Milne, S.
(2002) Focus Groups to determine the issues that are important to
dementia sufferers and their spouse for use in a future patient-orientated
group? UK Dementia Research Group Annual Conference, Wolverhampton,
30th October 2002
Kessler, J., Kalbe, E.,
Smith, R., Bullock, R. A., Fischer, L., Calabrese, P., (2002) A
comparison of DemTectâ subtests with the Mini-Mental State Examination
in patients with dementia, individuals with mild cognitive impairment,
and aged controls. 6th congress of the European Federation of Neurological
Societies Vienna, Austria, 26th - 29th October 2002
Bullock, R. A., Sorensen,
S., Shih, Y. T., Prasad, M., Sadik, K., Meletiche, D., (2002) Analysis
of the Risk of Falls and Cost Consequences in Patients Receiving Galantamine
or Placebo. 6th congress of the European Federation of Neurological
Societies Vienna, Austria, 26th - 29th October 2002
Bullock, R. A., Erkinjuntti,
T., Kafferlein, W., Wetterberg, P., Murthy, A., Blackburn, S., Bahra,
R., (2002) Greater improvement in cognition and activities of
daily living with Donepezil compared to Galantamine in a direct head
to head trial in Alzheimer patients. 6th congress of the European
Federation of Neurological Societies Vienna, Austria, 26th - 29th October
2002
Truyen, L., Bullock,
R. A., Lilienfeld, S., Coles, H., and Members of the GAL-GBR-2 Study
Group (2002) Galantamine demonstrates superior efficacy MMSE
and attention compared with donepezil in patients with Alzheimer's disease
actively treated for 52 weeks: an initial analysis. 6th congress
of the European Federation of Neurological Societies Vienna, Austria,
26th - 29th October 2002
Bullock, R. A., Gambina,
G., Lane, R., Nagel, J., (2002) Rationale and design of EXEED,
a 24-month, double-blind study comparing rivastigmine and donepezil.
127th Annual Meeting of the American Neurological Association, New York,
USA, 13th - 16th October 2002
Bullock, R. A., Sorensen,
S., Shih, T., Meletiche, D., Sadik, K., (2002) Analysis of the
risk of falls and cost consequences in patients receiving Galantamine
or placebo. 2nd Annual Meeting of the International College of Geriatric
Psychoneuropharmacology, Barcelona, Spain, 10th - 12th October 2002
Aarsland, D., Alhainen,
K., Bullock, R. A., Wetterberg, P., Smith, R., Soininen, H., Murthy,
A., Zhang, R., Bahra, R., (2002) First head-to-head study comparing
the tolerability and satisfaction/ease of use of donepezil and galantamine
in Alzheimer's disease. 15th Congress of the European College of
Neuropsychopharmacology, Barcelona, Spain, 5th - 9th October 2002
Soininen, H., Martin,
S., Bullock, R. A., Alhainen, K., Hager, K., Jones, R., Aarsland, D.,
Murthy, A., Zhang., Bahra, R., (2002) First head-to-head study
comparing the efficacy of donepezil and galantamine in Alzheimer's disease.
15th Congress of the European College of Neuropsychopharmacology,
Barcelona, Spain, 5th - 9th October 2002
Wesnes, K., Bullock, R.
A., (2002) Cholinesterase Inhibitors and Executive Function.
8th International Conference on Alzheimer's Disease and Related
Disorders Stockholm, Sweden, 21st - 25th July 2002
Passmore, P., Wetterberg
P., Adler, G., Bullock, R. A., Soininen, H., Aarsland, D., Murthy A.,
Zhang, R., Bahra, R, (2002) First Head to Head Study Comparing
the Tolerability, Ease of Use, And Efficacy of Donepazil and Galantamine
in Alzheimer's Disease. 8th International Conference on Alzheimer's
Disease and Related Disorders Stockholm, Sweden, 21st - 25th July 2002
Wesnes, K., Bullock,
R. A., (2002) Attention in the differential diagnosis of dementia.
8th International Conference on Alzheimer's Disease and Related Disorders
Stockholm, Sweden, 21st - 25th July 2002
Kessler, J., Kalbe, E.,
Smith, R., Bullock, R. A., Fischer, L., Calabrese, P., (2002)
Correlation analysis of DemTect® subtests with the Mini-Mental State
Examination in patients with dementia, mild cognitive impairment, and
aged controls 8th International Conference on Alzheimer's Disease
and Related Disorders Stockholm, Sweden, 21st - 25th July 2002
Bullock, R. A., Saharan,
A., (2002) Cigarette smoking as a differential diagnosis of cognitive
impairment 8th International Conference on Alzheimer's Disease and
Related Disorders Stockholm, Sweden, 21st - 25th July 2002
Marriott, A., Bullock,
R. A., (2002) Functional change before dementia 8th International
Conference on Alzheimer's Disease and Related Disorders Stockholm,
Sweden, 21st - 25th July 2002
Thomas, K., Marriott,
A., Bullock, R. A., (2002) The evolving role of a memory clinic
8th International Conference on Alzheimer's Disease and Related Disorders
Stockholm, Sweden, 21st - 25th July 2002
Bullock, R. A., (2002)
Optimising treatment for patients with dementia Novartis CNS
Standalone Conference, Hamburg, Germany, 25th June 2002
Bullock, R. A., Truyen,
L., (2002) Long-term Response to Galantamine in Patients With
Alzheimer's Disease (AD), Vascular Dementia or AD With Cerebrovascular
Disaease. European Neurological Society Meeting, Berlin, Germany,
22nd - 26th June 2002
Kalbe, E., Kessler, J.,
Smith, R., Bullock, R. A., Fischer, L., Calabrese, P., (2002) The
Demtect®: a very sensitive screening instrument for mild dementia
11th Congress of the Association of European Psychiatrists, Stockholm,
Sweden, 4th - 8th May 2002
Kessler, J., Kalbe, E.,
Smith, R., Bullock, R. A., Fischer, L., Calabrese, P., (2002) A
comparison of DemTectâ subtests with the Mini-Mental State Examination
in patients with dementia, individuals with mild cognitive impairment,
and aged controls. International Psychiatric Association European
and Mediterranean Regional Meeting, Rome, Italy, 17th - 20th April 2002
Kessler, J., Kalbe, E.,
Smith, R., Bullock, R. A., Fischer, L., Calabrese, P., (2002) The
Demtect®: a novel and highly sensitive screening instrument for
mild vascular and Alzheimer's dementia 7th International Geneva/Springfield
Symposium on Advances in Alzheimer Therapy Geneva, Switzerland, 3rd
- 6th April 2002
Bullock, R. A., Lilienfeld,
S., (2002) Galantamine shows promising results in Alzheimer's
Disease with cerebrovascular components and probable vascular dementia
(preliminary results). Janssen Stand-alone Meeting - "Neuroscience
in Action", Hamburg, Germany, 22nd - 23rd March 2002.
Bullock, R. A., (2002)
Optimising treatment for patients with dementia. Janssen Stand-alone
Meeting - "Neuroscience in Action", Hamburg, Germany, 22nd
- 23rd March 2002.
Edwards, R., Cima, L.,
Holland, J., Bullock, R. A., (2002) Revalidation of the 6-CIT
using a genuine memory clinic population. The British Psychological
Society Annual Conference 2002, Blackpool, 13th - 16th March 2002
Holland, J. D., Cima,
L.C., Passfield, K. W. , Voss, S. E., Bullock, R. A., (2002) The
Hopkins Verbal learning Test: Can it distinguish between dementing and
non-dementing patients? The British Psychological Society Annual
Conference 2002, Blackpool, 13th - 16th March 2002
Marriott, A., Bullock,
R. A., (2002) The Evolving Role of a Memory Clinic. The British
Psychological Society Annual Conference 2002, Blackpool, 13th - 16th
March 2002
Thomas, K., Bullock, R.
A., (2002) The Clock Drawing Test: Does it differentiate between
type and severity of dementia? The British Psychological Society
Annual Conference 2002, Blackpool, 13th - 16th March 2002
Bullock, R. A., Connolly,
C., (2002) Switching Cholinesterase inhibitor therapy in Alzheimer's
disease - UK experience. Novartis CNS Standalone Conference, Prague,
Czech Republic, 28th February - 3rd March 2002
Bullock, R. A. (2002)
Effects of rivastigmine treatment on behavioural symptoms in nursing
home patients with AD. Novartis CNS Standalone Conference, Prague,
Czech Republic, 28th February - 3rd March 2002
Bullock, R. A. (2002)
Differential diagnosis in primary progressive aphasia. AAGP 15th
Annual Meeting, Orlando, Florida, 24th - 27th February 2002
Bullock, R. A. (2002)
The effect of cholinesterase inhibitors on executive function in Alzheimer's
disease. AAGP 15th Annual Meeting, Orlando, Florida, 24th - 27th
February 2002
Kalbe, E., Kessler, J.,
Smith, R. A., Bullock, R., Fischer, L., Calabrese, P.,(2002)
DemTect®: a new screening instrument with very high sensitivity
for vascular and Alzheimer dementia, Second International Congress
on Vascular Dementia, Salzburg, Austria, 24th - 27th January 2002
[2001]
Bullock, R. A., (2001)
Switching cholinesterase inhibitor therapy in Alzheimer's disease
- donepezil to rivastigmine, is it worth it? Alzheimer's Disease
International 17th International Conference, Christchurch, New Zealand,
25th - 27th October 2001
Bullock, R. A., (2001)
Managing patient and caregiver expectations when switching therapies
in Alzheimer's disease. Alzheimer's Disease International 17th International
Conference, Christchurch, New Zealand, 25th - 27th October 2001
Bullock, R. A.,
(2001) Switching cholinesterase inhibitor therapy in Alzheimer's
disease - UK experience. 14th European College of Neuropsychopharmacology
Congress, Istanbul, Turkey, 13th - 15th October 2001 (Conference Cancelled)
Bullock, R.A., (2001)
Effects of rivastigmine on behavioural symptoms in nursing home patients
with Alzheimer's disease. 14th European College of Neuropsychopharmacology
Congress, Istanbul, Turkey, 13th - 15th October 2001 (Conference Cancelled)
Naidoo, M. J., (2001)
"Breaking down the walls of silence" (storyboard presentation).
International Society for Quality in Health Care - 18th International
Conference, Buenos Aries, Argentina, 2nd - 5th October 2001.
Holland, J. D., Cima,
L.C., Passfield, K. W., Voss, S.E., Bullock, R. A., (2001) The
usefulness of the Hopkins Verbal learning Test in a UK population, for
distinguishing between dementing and non-dementing older adults. UK
Dementia Research Group Conference, Winchester, 21st September 2001.
Naidoo, M., Bullock, R.
A., (2001) Dementia Collaborative - the development of an integrated
care pathway for dementia. Tenth Congress of the International Psychogeriatric
Association, Nice, France, 9th - 14th September 2001.
Bullock, R. A., Moulias,
R., Steinwachs, K. C., Cicin-Sain, A., Spiegel, R., (2001) Effects
of Rivastigmine on behavioural symptoms in nursing home patients with
Alzheimer's disease. Tenth Congress of the International Psychogeriatric
Association, Nice, France, 9th - 14th September 2001.
Bullock, R. A., Connolly,
C., (2001) Switching cholinesterase inhibitor therapy in Alzheimer's
disease - UK experience. Tenth Congress of the International Psychogeriatric
Association, Nice, France, 9th - 14th September 2001.
Bullock, R.A., (2001)
Health Technology Assessments in Alzheimer's Disease. Tenth Congress
of the International Psychogeriatric Association, Nice, France, 9th
- 14th September 2001.
Bullock, R. A., Saharan,
A., (2001) Do anticholinergic drugs affect Alzheimer's disease
and its treatment? - UK experience. Tenth Congress of the International
Psychogeriatric Association, Nice, France, 9th - 14th September 2001.
Bullock, R. A., Lilienfeld,
S., Hammond, G., (2001) The broad, sustained efficacy of Galantamine
in patients with mixed or vascular dementia. European Union Geriatric
Medicine Society Paris, France, 29th August - 1st September 2001
Bullock, R. A., Lillenfeld,
S., (2001) Galantamine shows promising results in Alzheimer's
Disease with cerebrovascular components and probable vascular dementia
(preliminary results). XVII World Congress of Neurology. London
17th - 22nd June 2001.
Holland, J. D., Cima,
L.C., Passfield, K. W., Voss, S.E., Bullock, R. A., (2001) The
usefulness of the Hopkins Verbal learning Test in a UK population, for
distinguishing between dementing and non-dementing older adults.
3rd Memory Clinic Conference, Reading, 5th June 2001
Connolly, C., (2001)
A brief history of a memory clinic. 3rd Memory Clinic Conference.
Reading, 5th June 2001
Bullock, R. A. Passmore,
P., Potocnik, F., Hock, C.,
(2001) The tolerability , ease of use and efficacy of Donepezil and
Rivastigmine in Alzheimer's disease patients: a 12-week , multinational,
comparative study. Annual Meeting of the American Geriatrics Society,
Chicago, USA, 9th - 13th May 2001.
Bullock, R.A., Connolly,
C., (2001) Should the ADAS-cog be used as a clinical instrument?.
BPS Centenary Annual Conference, Glasgow 28th - 31st March 2001
Bullock, R. A., Switching
cholinesterase inhibitors: is it worth it? Faculty of Old Age Psychiatry
Annual Meeting, Dublin, March 2001
Bullock, R. A., Should
ADAS be used in routine clinical practice? Faculty of Old Age Psychiatry
Annual Meeting, Dublin, March 2001
Voss, S.E., Bullock, R.
A., (2001) The neuropsychological differentiation of Alzheimer's
disease and vascular dementia; the role of executive functioning. BPS
Centenary Annual Conference, Glasgow 28th - 31st March 2001``
[2000]
Moore, C.T.A., Voss, S.E.,
Bullock, R.A. (2000) The Token Test: Validation and Screening
Power in Alzheimer's Disease. 1st International Quality Research
in Dementia Conference. London, 19th - 22nd November 2000.
Qizilbash, N., Bullock,
R. A., Why Dementia Needs n-of-1 Trials. UK Dementia Research
Group Annual Meeting. Cardiff, 28th September 2000.
Bullock R. A., Naidoo,
M. J., (2000) The Development of an Integrated Care Pathway for
Dementia. UK Dementia Research Group Annual Meeting, Cardiff, 28th September
2000.
Voss, S. E., Passfield,
K. W., Bullock, R. A., Utilisation and Validation of the Bristol
Activities of Daily Living Scale (BADLS) With People With Dementia
. UK Dementia Research Group Annual Meeting. Cardiff, 28th September
2000.
Morrison, P., Voss, S.
E., Bullock, R. A., The Alzheimer's Disease Assessment Scale
(ADAS) In Clinical Practice: Utilisation of the Word Recognition Task.
UK Dementia Research Group Annual Meeting. Cardiff, 28th September 2000.
Cottis E. R., Bullock
R. A., Assessing And Recording Risk In Old Age Psychiatry - The
Development Of An EMI Risk Assessment Tool. 17th International Conference
of the International Society for quality in Health Care. Dublin Ireland,
13th - 16th September 2000 .
Bullock, R. A., Voss,
S. E. (2000) The clinical utility of Donepizil: From randomised
clinical trials to practice. World Alzheimer's Congress 2000, Washington
USA, July 9-18 2000.
Bullock, R. A., The
relevance Mild Cognitive Impairment (MCI) has in routine clinical elderly
services. The Royal College of Psychiatrists Annual Meeting Edinburgh
3rd - 7th July 2000.
Bullock R. A.,
Financial Benefits Of Multi-agency Integration. Joint Meeting International
Psychogeriatric Association and Royal College of Psychiatrists Faculty
of Old Age 4th - 7th April 2000 Newcastle.
Cottis E. R., Bullock
R. A., Risk Assessment In Old Age Psychiatry - A Simple Tool
For Risk Screening. Joint Meeting International Psychogeriatric
Association and Royal College of Psychiatrists Faculty of Old Age 4th
- 7th April 2000 Newcastle
Bullock R. A., Voss S.
E., The Relevance Of Mild Cognitive Impairment (MCI) In Routine
Clinical Assessment. Joint Meeting International Psychogeriatric
Association and Royal College of Psychiatrists Faculty of Old Age 4th
- 7th April 2000 Newcastle
Bullock R. A., The
Development Of Integrated Community Mental Health Services For Older
People In Swindon. 5th European Forum on Quality Improvement in
Healthcare 23rd - 25th March 2000 Amsterdam.
[1999]
Voss, S. E., Elcock, J.,
Bullock, R. A. (1999) Caregiver Stress in dementia: The role
of ADL and behavioural patterns. IPA: Ninth Congress "Challenges
for the new Millennium", at Vancouver, Canada, August 1999
Voss, SE, Elcock, J.,
Bullock, R. A., (1999) Neuropsychological differentiation of
Dementia with Lewy Bodies from Alzheimer's Disease. IPA: Ninth Congress
"Challenges for the new Millennium", at Vancouver, Canada,
August 1999
Voss, S. E., Elcock,
J., Bullock, R. A., (1999) An investigation of the utility of
the Hopkins Verbal Learning Test as a method of distinguishing between
dementing and non-dementing older adults. The BPS 1999 Annual Conference
at Waterfront Hall, Belfast, 8-11 April 1999
Voss, S. E., Elcock,
J., Bullock, R. A., (1999) A memory clinic in a department of
old-age psychiatry: Its role in assessment and its clinical outcomes.
The BPS 1999 Annual Conference at Waterfront Hall, Belfast, 8-11 April
1999
Bullock, R. A., (1999)
Integration with Social Service teams in the community - are you there
and is it worth it? The Royal College of Psychiatrists, Psychiatry
of Old Age, Annual Residential Meeting Cardiff, UK, March 1999
Brooke, P., Bullock,
R. A., (1999) Screening for dementia in primary care: Validation
of the 6 Item Cognitive Impairment Test (6-CIT). The Royal College
of Psychiatrists, Psychiatry of Old Age, Annual Residential Meeting
Cardiff, UK, March 1999
[1998]
Voss, S. E., Bullock,
R. A., Burgess, I.S., Elcock, J., (1998) Differential cognitive
impairment in dementia according to MMSE scores. IPA/Munich '98;
Munich, Germany, September 1998
Voss, S. E., Bullock,
R. A., Elcock, J., Burgess, I.S., (1998) Patterns of neuropsychological
features differentiating between Dementia with Lewy Bodies and Alzheimer's
Disease. 6th International Conference on Alzheimer's Disease and
Related Disorders; at Amsterdam, Holland, July 1998
Bullock, R. A., (1998)
The Benefits of integrated CMHT's in Old Age Psychiatry services.
2nd South West Public Health Conference Somerset, May 1998
Voss, S. E., Bullock,
R. A., Burgess, I. S., Elcock, J., (1998) Referrals to a Memory
Clinic in a Department of Old-Age Psychiatry: Sources and Outcomes.
The UK Dementia Research Group Conference; at the University of Leicester,
April 1998
[1996]
Burgess, I. S., Bullock,
R. A., Stevens, L., (1996) The Salford Objective Recognition
Test: A Study with Dementia Patients. International Congress on
Drugs and Therapeutics in the Elderly, Canada, 16th August 1996.
INVITED TALKS,PRESENTATIONS,
ROUNDTABLES & WORKSHOPS, ETC.
[2003]
Bullock, R. A. (2003)
Chair - 1st Day Memory International 2003, London, UK, 9th - 10th
July 2003
Bullock, R. A. (2003)
Debate - Is Mild Cognitive Impairment a Useful Clinical Entity?
Memory International 2003, London, UK, 9th - 10th July 2003
Bullock, R. A., (2003)
Invited Speaker BAMM Annual Conference, York, UK, 11th - 13th
June 2003.
Bullock, R. A., (2003)
Treatment Goals in Alzheimer's Disease: Managing Cognitive, Functional
and Behavioural Decline. Janssen Pharmaceutica Symposium at the
American Geriatric Society Annual Meeting, Baltimore, USA, 14th - 18th
May 2003.
Bullock, R. A., (2003)
Benefits of Dual Cholinesterase Inhibition, "Dementia: A Dual
Approach Meeting", Dementia Plus Conference, Birmingham, UK, 6th
May 2003
Bullock, R. A., (2003)
Geriatric neuropsychiatry drug development: Recent trials and developments.
CNS Product Development, London, UK, 1st - 2nd April 2003
Bullock, R. A., (2003)
Existing Head to Head Clinical Trials. Reminyl Dementia Focus Group,
New York, USA, 26th - 27th January 2003.
[2002]
Bullock, R. A., (2002),
Treatment of Behavioural and Psychological Symptoms in Dementia.
British Association for Psychopharmacology, 3rd December 2002
Bullock, R. A., (2002),
Invited speaker, Age Concern Away Day, 6th December 2002
Bullock, R. A., (2002)
Efficacy and safety of Rivastigmine in patients with AD who failed
to benefit from treatment with Donepezil. Novartis Exelon Symposia,
Istanbul, Ankara & Izmir, Turkey, 17th - 19th September 2002.
Bullock, R. A., (2002)
Latest methodological advances in evaluating anti-dementia therapies.
Contemporary Dementia Research - A Cognitive Drug Research Seminar,
Reading, 11th July 2002.
Naidoo, M. J., (2002)
Using Complexity Science and Creative Arts to Improve Practice Healthy
Babies Programme, National Clinical Governance Team, 5th July, York,
2002.
Naidoo, M. J., Bullock.
R. A. (2002) Implementing a care pathway for Dementia. National
Pathways Association Conference, London, 3rd July 2002.
Naidoo, M. J., (2002)
Effective Communication with Patients and colleagues Modernisation
Agency A.B.C., Brighton. 3rd July 2002.
Naidoo, M. J., Bullock,
R. A. (2002) Implementing a care pathway for Dementia, Dementia
Conference, London, 2nd July 2002.
Naidoo, M. J., (2002)
Creative Chaos, Modernisation Agency A.B.C. Birmingham, June
2002.
Naidoo, M. J. (2002)
Creative Chaos, Post Graduate Research Students Conference, University
of Bath, 28th June 2002.
Naidoo, M. J. (2002)
Creative Chaos, NIMHE Launch, Newcastle, 25th - 26th June 2002.
Bullock, R. A., (2002)
Optimising pharmacotherapy in elderly patients Collegium Internationale
Neuro-psychopharmacologium - Janssen-Cilag Satellite Symposium "Patient-centred
management of BPSD across treatment settings - A refined approach to
symptom management in elderly patients with dementia", Montreal,
Canada, 23rd - 27th June 2002
Naidoo, M. J., Bullock,
R. A., (2002). Developing Creative Leaders, British Association
of Medical Managers Annual Summer School, London, June 2002.
Naidoo, M. J., (2001)
"I am because we are" National Assembly for Wales,
Cardiff, May 2002.
Naidoo, M. J., Bullock,
R. A. (2002) Implementing a care pathway for Dementia, Radcliffe
Informary, Oxford, 22nd May 2002.
Naidoo, M. J., Bullock,
R. A., (2002) Quality improvement and developing best practice
in health care East Meets West to Improve Quality and Efficiency
of Health Services Bucharest, Romania, 10th - 12th April 2002
Naidoo, M. J., (2002)
"Quality Improvement in Health Care". 7th European Forum
on Quality Improvement in Health Care, 21st - 24th March 2002
Bullock, R. A., (2002)
Optimising treatment for patients with dementia. Janssen-Cilag
Nueroscience in Action Meeting, Hamburg, Germany, March 2002
Naidoo, M. J. (2002)
Using Complexity Science and Creativity to Improve Practice.
National Patients Access Team, Leicester, March 2002.
Naidoo, M. J., (2002)
Using Complexity Science and Creativity to Improve Practice.
National Clinical Governance Programme, Leicester, 2002.
Naidoo, M. J., Bullock.
R.A., & Brooke, P. (2002) Implementing a pathway for Dementia,
Fairmile, February 2002
[2001]
Bullock, R. A., (2001)
Practical experience in the treatment of behavioural and psychological
symptoms in dementia. BAP Certificate in Psychopharmacology - "Drug
Treatments in Old Age Psychiatry", Manchester, 7th - 8th December
2001
Bullock, R. A., (2001)
Younger People with Dementia National Conference, London, 8th November
2001
Bullock, R. A., (2001)
Old Age Psychiatry Meeting - 'Dementia Services for the Future' (Chair)
Broxbourne, 7th November 2001
Naidoo, M. J., (2001)
"The Creative Practitioner". 18th International Conference
of the International Society for Quality in Health Care. Buenos Aries,
Argentina, 2nd - 5th October 2001
Naidoo, M. J.,
(2001) "The Performing Practitioner" - Creative approaches
to professionalism and leadership. RCN Conference - Innovation,
creativity, patient care and professionalism, 12th - 14th September
2001
Naidoo, M. J., Bullock,
R. A. (2002) Implementing a care pathway for dementia, Modernising
Dementia Services, Bowood House, Chippenham, 9th September 2001.
Naidoo, M. J., Bullock,
R. A. (2001) "Mind the Gap" - a series of workshops
for staff working with Dementia. UK & Belfast, July and September
2001.
Naidoo, M. J., (2001)
Developing a Creative Clinical Governance Programme. South and West
Quality Network Group, Devon, September 2001.
Naidoo, M. J., (2001)
Working Creatively within your Team. Royal United Hospital, Bath,
August 2001.
Naidoo, M. J. (2001)
Using Creativity to Develop Team Dynamic. Royal College of Nursing
Leadership Programme, Wales, July 2001.
Naidoo, M. J., (2001)
Developing a Creative Clinical Governance Programme. Royal United
Hospital, Bath, July 2001.
Naidoo, M. J., (2001)
Developing a care pathway. Newcastle University. Newcastle, 4th
July 2001
Bullock, R. A. (2001)
"Practical guidelines for the use of Galantamine" -
Meet the Expert Session XVII World Congress of Neurology. London, UK,
19th June 2001.
Naidoo, M. J., (2001)
Developing a creative approach to clinical governance. Bro Morgannwg
Annual Nursing Conference. 26th June 2001.
Naidoo, M. J., (2001)
"The performing manager". BAMM AGM - Patients and Clinicians,
the modern partnership. Liverpool, 14th June 2001
Brooke, P., (2001)
Implications of Nice Guidelines on Primary Care. Dementia Care
in the Community Conference, Birmingham, April 2001
Rose, C. A., Warren, A.,
The Forget Me Not Centre in Swindon - a quality based service
for younger people with dementia. Educational Seminar "Clinical
Governance in Mental Health Services", London 15th March 2001.
Naidoo, M. J., Bullock.
R.A., & Brooke, P. (2001) Implementing a pathway for Dementia,
Newbury, 2001.
Naidoo, M. J., (2001)
Resolving conflict. Royal College of Nursing Leadership Programme,
Glasgow, January 2001.
Bullock, R. A., (2001)
Switching strategies with cholinesterase inhibitors. Novartis
World Symposium Istanbul, Turkey 2001.
Bullock, R. A., (2001)Major
Contributor. Helsinki Vascular Dementia Roundtable, Helsinki, Iceland
2001.
|
